文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症患者30天再入院的流行病学与预测因素

Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis.
PubMed 文献 · Chest · 2019-01-01
一句话结论脓毒症出院后30天再入院率17.5%,中位11天,感染为最常见病因(42.16%,其中脓毒症22.86%),合并症与出院去向可预测再入院。

该研究利用2013至2014年美国HCUP全国再入院数据库,纳入1,030,335例脓毒症索引住院患者(平均年龄66.8±17.4岁,60%年龄≥65岁),其中898,257例(87.2%)存活出院。157,235例(17.5%)发生30天再入院,中位再入院时间11天(四分位距5-19天)。再入院病因以感染最常见(42.16%,其中脓毒症占22.86%),其次为胃肠(9.6%)、心血管(8.73%)、肺(7.82%)和肾脏(4.99%)。糖尿病、慢性肾病、充血性心力衰竭、出院至短期/长期机构、Charlson合并症指数≥2及索引住院时长≥3天与30天再入院风险升高相关;每次再入院平均费用16,852美元,美国年费用超过35亿美元。

要点

  • 脓毒症存活出院患者30天再入院率为17.5%(157,235/898,257),中位再入院时间11天(四分位距5-19天)。
  • 再入院最常见病因为感染(42.16%),其中脓毒症占22.86%;其次为胃肠(9.6%)、心血管(8.73%)、肺(7.82%)、肾脏(4.99%)。
  • 充血性心力衰竭(OR 1.16,95%CI 1.14-1.18,P<.001)、慢性肾病(OR 1.12,95%CI 1.10-1.14,P<.001)、糖尿病(OR 1.07,95%CI 1.06-1.08,P<.001)及出院至短期/长期机构(OR 1.13,95%CI 1.11-1.14,P<.001)与30天再入院风险升高相关。
  • Charlson合并症指数≥2及索引住院时长≥3天亦为30天再入院的显著预测因素。
  • 每次再入院平均费用16,852美元,美国年费用超过35亿美元。

适用人群与场景

  • 2013至2014年HCUP全国再入院数据库中因脓毒症入院的患者,涵盖所有年龄和保险状态。
  • 索引住院后存活出院的脓毒症患者(898,257例,占87.2%)。

研究设计与关键结果

  • 研究类型:基于大型行政数据库的队列研究;样本量1,030,335例索引住院,平均年龄66.8±17.4岁,60%年龄≥65岁。
  • 主要结局:30天再入院率17.5%(157,235例),中位再入院时间11天(四分位距5-19天)。
  • 再入院病因:感染42.16%(其中脓毒症22.86%)、胃肠9.6%、心血管8.73%、肺7.82%、肾脏4.99%。
  • 预测因素:糖尿病OR 1.07(95%CI 1.06-1.08,P<.001)、慢性肾病OR 1.12(95%CI 1.10-1.14,P<.001)、充血性心力衰竭OR 1.16(95%CI 1.14-1.18,P<.001)、出院至短期/长期机构OR 1.13(95%CI 1.11-1.14,P<.001);Charlson合并症指数≥2和索引住院时长≥3天亦为显著预测因素。
  • 费用:每次再入院平均费用16,852美元,美国年费用超过35亿美元。

证据类型、等级与局限

  • 证据类型:基于行政数据库的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 脓毒症患者出院后30天内再入院常见且费用高昂,再入院多与感染病因相关,作者认为需进一步明确再入院的决定因素并制定旨在改善医疗质量和照护过渡的策略以预防该结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients with sepsis are particularly vulnerable to readmissions. We describe the associated etiology and risk factors for readmission in patients with sepsis using a large administrative database inclusive of patients of all ages and insurance status.

METHODS: Our study cohort was derived from the Healthcare Cost and Utilization Project's National Readmission Data from 2013 to 2014 by identifying patients admitted with sepsis. The primary outcome was 30-day readmission with etiology identified by using International Classification of Diseases, Ninth Revision, Clinical Modification, codes.

RESULTS: From a total 1,030,335 index admissions; mean age, 66.8 ± 17.4 years (60% age ≥65 years), 898,257 patients (87.2%) survived to discharge. A total of 157,235 (17.5%) patients had a 30-day readmission; median time to readmission was 11 days (interquartile range, 5-19). Infectious etiology (42.16%; including sepsis, 22.86%) was the most commonly associated cause for 30-day readmission followed by gastrointestinal (9.6%), cardiovascular (8.73%), pulmonary (7.82%), and renal causes (4.99%). Significant predictors associated with increased 30-day readmission included diabetes (OR, 1.07; 95% CI, 1.06-1.08; P < .001), chronic kidney disease (1.12;1.10-1.14, P < .001), congestive heart failure (OR, 1.16; 95% CI, 1.14-1.18; P < .001), discharge to short-/long-term facility (OR, 1.13; 95% CI, 1.11-1.14; P < .001), Charlson comorbidity index ≥ 2, and length of stay ≥ 3 days during the index admission. The mean cost per readmission was $16,852; annual cost was > $3.5 billion within the United States.

CONCLUSION: We describe that readmission after a sepsis hospitalization is common and costly. The majority of readmissions were associated with infectious etiologies. The striking rate of readmission demands efforts to further clarify the determinants of readmission and develop strategies in terms of quality of care and care transitions to prevent this outcome.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Gadre SK, Shah M, Mireles-Cabodevila E, et al. Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis. Chest. 2019. PMID: 30846065. doi:10.1016/j.chest.2018.12.008

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。